Marc Goodman analyst

Currently out of the existing stock ratings of Marc Goodman, 185 are a BUY (77.73%), 47 are a HOLD (19.75%), 6 are a SELL (2.52%).

Marc Goodman

Work Performance Price Targets & Ratings Chart

Analyst Marc Goodman works with a stock forecast success ratio of 60.61% fulfilled within 249 days on average. Previously, Marc Goodman worked at LEERINK.

Marc Goodman’s has documented 433 price targets and ratings displayed on 42 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 11-Mar-2024.

Wall Street Analyst Marc Goodman

Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $270 was fulfilled within 3 days with a profit of $41.55 (18.19%) receiving and performance score of 60.63.

Average potential price target upside

ABBV AbbVie ACAD ACADIA Pharmaceuticals AGN Allergan plc ALDX Aldeyra The AXSM Axsome Therapeutics BHVN Biohaven Pharmaceutical Holding Co Ltd BMY Bristol-Myers Squibb Company GILD Gilead Sciences GMTX Gemini Therapeutics JAZZ Jazz Pharmaceuticals PLC LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MYL Viatris NBIX Neurocrine Biosciences PRGO Perrigo Company PLC REGN Regeneron Pharmaceuticals SAGE Sage Therapeutic VRTX Vertex Pharmaceuticals ZGNX Zogenix ALKS Alkermes Plc HZNP Horizon Pharma PLC APTX Aptinyx AVDL Avadel Pharmaceuticals PLC GRAY Graybug Vision KRTX Karuna Therapeutics AMLX Amylyx Pharmaceuticals ELYM Eliem Therapeutics MRNS Marinus Pharmaceuticals VTRS Viatris XENE Xenon Pharmaceuticals ITCI Intracellular Th STSA Satsuma Pharmaceuticals BIIB Biogen ACIU AC Immune Ltd ADMS Adamas Pharmaceuticals ENDP Endo International PLC EOLS Evolus GWPH GW Pharmaceuticals plc NEOS Neos Therapeutics PFE Pfizer RLMD Relmada Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

187

$20.58 (12.37%)

195

20 days ago

10/13 (76.92%)

$27.38 (17.15%)

191

Buy

189

$22.58 (13.57%)

181

3 months 13 days ago

9/11 (81.82%)

$15.71 (9.07%)

252

Buy

195

$28.58 (17.17%)

180

3 months 13 days ago

9/10 (90%)

$21.71 (12.53%)

445

Hold

165

$-1.42 (-0.85%)

157

4 months 2 days ago

11/11 (100%)

$2.96 (1.83%)

314

Buy

180

$13.58 (8.16%)

195

4 months 16 days ago

3/5 (60%)

$21.06 (13.25%)

496

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Marc Goodman is most bullish on?

Potential upside of $0 has been obtained for AMLX (AMYLYX PHARMACEUTICALS)

What Year was the first public recommendation made by Marc Goodman?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?